Clinical Trials Browser

Phase 2 × Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence × Clear all

NCT06280508 2024-04-23

Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer

Phase 2 Recruiting

Gastrointestinal

Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence